Treatment of moderate-to-severe atopic dermatitis in the elderly may be challenging, due to side effects of traditional anti-inflammatory drugs and to comorbidities often found in this age group. Furthermore, efficacy and safety of innovative drugs such as dupilumab is not yet well known.
Dupilumab therapy of atopic dermatitis of the elderly: a multi-centre, real-life study
Napolitano, M;Foti, C;
2020-01-01
Abstract
Treatment of moderate-to-severe atopic dermatitis in the elderly may be challenging, due to side effects of traditional anti-inflammatory drugs and to comorbidities often found in this age group. Furthermore, efficacy and safety of innovative drugs such as dupilumab is not yet well known.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dupilumab therapy.pdf
accesso aperto
Descrizione: articolo principale
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright dell'editore
Dimensione
279.12 kB
Formato
Adobe PDF
|
279.12 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
